
Instem Joins Ansys Technology Partner Program to Integrate Leadscope With CertiSim for Advanced Packaging Toxicology and Safety Assessment
Instem, a leading provider of software solutions for life sciences research and regulatory operations across preclinical and clinical research and development (R&D), has announced that it is joining the Ansys Technology Partner Program, which is now part of Synopsys. Through this collaboration, Instem plans to develop an integration between its Leadscope Model Applier™ platform and the CertiSim packaging toxicology and safety assessment platform.
The integration is intended to combine advanced toxicological intelligence with predictive migration and exposure simulation capabilities, helping organizations improve the assessment of extractables and leachables (E&L) risks associated with product packaging materials. By bringing together the complementary capabilities of the two platforms, the collaboration aims to provide a more comprehensive approach to evaluating chemical substances that may migrate from packaging into pharmaceutical products, cosmetics, consumer health products and other materials intended for human use.
The partnership addresses an important and increasingly complex challenge for manufacturers across the pharmaceutical, cosmetics, personal care, consumer health and specialty chemicals industries. As organizations introduce new packaging materials, formulations and product delivery systems, understanding the potential migration of chemical substances from packaging into products has become an essential component of product safety evaluation.
Packaging materials may contain various chemical compounds that can migrate into the products they are designed to protect. These substances, commonly referred to as extractables and leachables, require careful evaluation to determine their potential impact on product quality and consumer safety. Manufacturers must understand not only which chemicals may be present but also whether those substances can migrate under actual storage and usage conditions, the extent of potential exposure and whether the resulting exposure levels could create safety concerns.
Through the planned integration, Instem and Synopsys aim to help customers connect chemical hazard identification with migration prediction and exposure assessment. This approach is expected to support more informed decision-making during product development and packaging safety evaluations.
Combining Leadscope Toxicological Intelligence With CertiSim Simulation Capabilities
The planned integration will bring together two specialized technology platforms designed to address different but complementary aspects of chemical safety assessment.
Instem’s Leadscope Model Applier is designed to provide toxicological intelligence through chemical structure analysis, structure-activity relationship (SAR) information and regulatory knowledgebases. These capabilities can help scientists and safety assessors evaluate chemical substances, identify potential toxicological concerns and understand the available information associated with compounds detected during extractables and leachables investigations.
The CertiSim packaging toxicology and safety assessment platform provides predictive simulation capabilities focused on understanding how chemical substances may migrate from packaging materials into products. Its capabilities are intended to support migration prediction, consumer exposure estimation and safety margin evaluation under different conditions that reflect real-world product use.
By connecting these capabilities, the companies aim to provide customers with a more integrated workflow for assessing the potential risks associated with chemicals identified in packaging systems.
Under the collaboration, CertiSim users will be able to leverage Leadscope’s extensive toxicology information, chemical structure-activity relationship data and regulatory knowledgebase. This additional information is expected to help users make more informed assessments of substances identified as potential leachables.
At the same time, Leadscope users will benefit from CertiSim’s predictive simulation capabilities. These tools are intended to help scientists better understand whether identified substances are likely to migrate from packaging materials, estimate the potential exposure of consumers and evaluate safety margins based on anticipated use conditions.
The combination is particularly relevant because identifying a potentially hazardous chemical does not automatically establish that a product presents a meaningful safety risk. A complete evaluation also requires understanding whether the substance can migrate into the product and whether the resulting exposure could reach levels of toxicological concern.
The integrated approach is designed to address both aspects of this assessment.
Addressing the Growing Importance of Extractables and Leachables Risk Assessment
Extractables and leachables testing plays an important role in evaluating the compatibility and safety of packaging materials used in pharmaceutical and consumer products.
Extractables are chemical substances that can be released from packaging materials under controlled laboratory extraction conditions. Leachables are substances that migrate from packaging into the product during actual storage, processing or use.
These substances can originate from different components of packaging systems, including polymers, elastomers, adhesives, coatings, inks and other materials used during manufacturing and packaging operations.
In pharmaceutical applications, packaging compatibility is particularly important because chemical migration may affect product quality, stability and patient safety. Pharmaceutical manufacturers must evaluate whether substances released from packaging could interact with drug formulations or expose patients to potentially harmful compounds.
Similar considerations apply to cosmetics, personal care products, food-contact materials and consumer health products. In these industries, packaging materials may remain in direct contact with products for extended periods, making migration behavior and exposure levels important considerations during safety assessments.
The challenge becomes more complex when manufacturers introduce new materials or develop products with different chemical compositions, storage requirements and usage patterns.
Traditional approaches to E&L assessment may require multiple stages of analytical testing, chemical identification, toxicological evaluation and exposure assessment. These activities can involve significant time and resources, particularly when numerous substances are identified and each requires further investigation.
The planned Leadscope and CertiSim integration is intended to help organizations connect these assessment activities through a more predictive and coordinated workflow.
By combining toxicological information with migration and exposure modeling, the platforms are expected to help scientists prioritize substances for further investigation and evaluate potential risks earlier in the product development process.
Moving Beyond Hazard Identification Toward Comprehensive Risk Assessment
One of the central objectives of the collaboration is to help organizations distinguish between the identification of a potential chemical hazard and the evaluation of actual consumer risk.
Hazard identification determines whether a chemical substance has properties that may cause adverse effects under certain conditions. However, understanding the potential risk associated with a substance also requires evaluating the amount of exposure and the circumstances under which exposure may occur.
For example, a chemical identified in a packaging material may have known toxicological concerns. However, the level of risk associated with that substance can depend on several additional factors, including its ability to migrate, the quantity that enters the product, the concentration to which consumers may be exposed and the intended conditions of product use.
Leadscope is designed to help determine whether a substance has known toxicological concerns based on available chemical and regulatory information. CertiSim complements this assessment by helping predict whether the substance is likely to migrate from packaging and potentially reach exposure levels that could be relevant to consumer safety.
Together, the platforms are intended to support a more complete evaluation of packaging-related chemical risks.
This approach may help manufacturers make better-informed decisions regarding packaging selection, formulation development, material compatibility and additional testing requirements.
It may also help organizations identify substances that require closer attention while supporting more efficient assessment of chemicals that are unlikely to present significant exposure-related concerns under the evaluated conditions.
The companies believe that combining these capabilities can help customers improve the efficiency of safety assessments while supporting stronger scientific and regulatory decision-making.
Leadership Highlights the Value of the Collaboration
Commenting on the collaboration, Vik Krishnan, chief executive officer of Instem, highlighted the importance of combining toxicological intelligence with predictive simulation to improve the understanding of chemical risks associated with packaging materials.
“By combining Leadscope’s trusted toxicological intelligence with CertiSim’s predictive simulation capabilities, we’re enabling customers to move beyond identifying potential hazards and toward a more complete understanding of actual risk,” Krishnan said.
His comments emphasize the importance of connecting chemical hazard information with realistic migration and exposure predictions. For manufacturers, this combination may provide additional insight into whether substances detected during packaging assessments could ultimately reach consumers at levels that warrant further investigation.
Dr. Mark Palmer, Field Chief Technology Officer for the New Ventures Group at Synopsys, also highlighted the potential benefits of bringing the two technologies together.
“Together, our solutions provide a comprehensive framework for predicting how packaging materials may interact with products earlier in the development process and assessing the potential impact on consumer safety,” Palmer added.
The comments reflect the shared objective of helping manufacturers incorporate predictive safety assessment into earlier stages of product development.
By evaluating packaging-related risks before products reach later development and manufacturing stages, organizations may be better positioned to identify potential issues, assess alternative materials and make adjustments when necessary.
Expected Benefits for Pharmaceutical and Consumer Product Manufacturers
The planned integration is expected to provide several benefits for organizations involved in pharmaceutical development, packaging evaluation and consumer product manufacturing.
One of the anticipated advantages is improved decision-making through the combination of toxicological and exposure-related information. Instead of evaluating chemical hazards and migration behavior as separate activities, users will be able to access complementary capabilities that support a more connected assessment process.
The integration is also expected to help accelerate product development by providing predictive information earlier in the development lifecycle.
Early identification of potential packaging-related risks can help manufacturers assess material compatibility and make informed decisions before committing significant resources to additional development activities.
Another potential advantage is reduced testing costs. By supporting predictive evaluation and helping prioritize substances for further investigation, the integrated workflow may help organizations focus laboratory testing resources on chemicals and scenarios that require additional attention.
The solution is also intended to strengthen regulatory confidence by providing a more comprehensive scientific framework for evaluating potential chemical exposures associated with packaging materials.
Although predictive modeling does not eliminate the need for appropriate analytical testing or regulatory review, it can provide valuable supporting information during risk assessment and help organizations better understand the factors influencing consumer exposure.
The combined solution is expected to support organizations across several industries, including:
- Pharmaceuticals: Assessment of substances that may migrate from drug packaging into pharmaceutical formulations.
- Cosmetics and personal care: Evaluation of chemical migration from containers, closures and other packaging components into cosmetic products.
- Consumer health products: Support for packaging compatibility and chemical safety evaluations.
- Food-contact materials: Assessment of substances that may migrate from packaging materials into food products.
- Specialty chemicals: Improved understanding of chemical hazards, migration characteristics and potential exposure scenarios.
- Consumer products: Support for product safety assessments involving packaging and material interactions.
These industries are experiencing increasing attention on product safety, packaging composition and chemical exposure. As a result, predictive tools that combine toxicological knowledge with migration simulation may become increasingly valuable for manufacturers seeking more efficient and scientifically supported assessment processes.
Ansys Technology Partner Program Expands Technology Collaboration
Instem’s participation in the Ansys Technology Partner Program provides an additional framework for collaboration between technology providers developing complementary software and simulation solutions.
The Ansys Technology Partner Program brings together companies across software, hardware, cloud computing and high-performance computing to develop and validate solutions that integrate with Ansys-branded simulation and analysis technologies from Synopsys.
Through these partnerships, Synopsys and its technology partners aim to help mutual customers optimize product performance, improve engineering workflows and accelerate product development.
The program supports collaboration among organizations with specialized technical capabilities, allowing them to combine their technologies to address complex industrial and scientific challenges.
For Instem, joining the program creates an opportunity to connect its established toxicological intelligence capabilities with CertiSim’s predictive packaging simulation technology.
The collaboration also reflects the increasing role of software integration and predictive modeling in pharmaceutical and consumer product safety assessment. As product development becomes more complex, organizations are increasingly seeking technology platforms that can connect data, scientific analysis and simulation within coordinated workflows.
By bringing Leadscope and CertiSim together, the companies aim to help customers gain a better understanding of chemical migration and potential consumer exposure while improving the efficiency of packaging safety evaluations.
Advancing Predictive Packaging Safety Assessment
The collaboration between Instem and Synopsys represents a step toward more integrated and predictive approaches to extractables and leachables risk assessment.
As pharmaceutical, cosmetics, food-contact and consumer product manufacturers continue to introduce new packaging materials and formulations, evaluating chemical migration and potential exposure will remain an important part of product safety development.
The planned integration of Leadscope Model Applier and CertiSim is intended to address this need by combining toxicological intelligence, chemical structure-activity information, regulatory knowledge and predictive migration simulation.
By connecting hazard identification with exposure assessment, the solution aims to help organizations move toward a more comprehensive understanding of packaging-related chemical risks.
The expected benefits include faster development decisions, more efficient testing strategies, improved assessment workflows and stronger scientific support for regulatory activities.
For additional information about Leadscope and the planned integration, interested organizations can contact Instem at info@instem.com or connect with their existing Instem account manager.
As the collaboration progresses, the combined capabilities are expected to provide pharmaceutical and consumer product manufacturers with additional tools to evaluate packaging interactions, understand potential chemical exposure and support consumer safety throughout product development.
About Instem
Instem is a leading supplier of SaaS platforms across Study Management, Regulatory, Lab Execution, Data Insights, and Clinical Trial Analytics. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life sciences and healthcare organizations for data-driven decision making leading to safer, more effective products.
Founded in the United Kingdom in 1969, Instem has deep roots internationally across North America, EMEA, and APAC. Instem maintains a commercial and technical presence throughout these regions and prides itself on localized support for its diverse client base.



